{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:48:12Z","timestamp":1789123692803,"version":"build-2803163510"},"reference-count":36,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ewha education and research center for infection","award":["20190052"],"award-info":[{"award-number":["20190052"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>We aimed to identify the presence of the measles IgG antibody (mIgG-Ab) in healthcare personnel and finding out who needs the measles vaccination. The history of measles vaccination was obtained from the national vaccine registry. A baseline mIgG-Ab test was performed, and the measles vaccine was administered to participants who tested negative or equivocal for mIgG-Abs. During the study, 2885 (87.3%) of the 3303 employees were tested for measles serostatus. The baseline seropositivity rate for mIgG-Abs was 91.9%. Among the 234 seronegative cases, 82.9% were born after 1985. The seroprevalence rate was lower in those who received the measles\u2013mumps\u2013rubella (MMR) vaccine &gt;10 years before the testing time, especially if they were born after 1985 and if there was only one previous record of vaccination. Among the 234 seronegative cases, MMR vaccination was administered in 174 cases, of which serostatus was evaluated in 146 cases. After the first dose, positive seroconversion was achieved in 126 participants (86.3%). After a second dose, 15 achieved (75.0%) positive seroconversion. In healthcare personnel born after the period when measles incidence significantly decreased, it may be necessary to reassess their immune status for measles if more than 10 years have elapsed since the last vaccination.<\/jats:p>","DOI":"10.3390\/vaccines9050501","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T22:46:14Z","timestamp":1620859574000},"page":"501","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination"],"prefix":"10.3390","volume":"9","author":[{"given":"Chung-Jong","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul 07804, Korea"},{"name":"Ewha Education and Research Center for Infection, Seoul 07985, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7475-4564","authenticated-orcid":false,"given":"Ji-Yun","family":"Bae","sequence":"additional","affiliation":[{"name":"Ewha Education and Research Center for Infection, Seoul 07985, Korea"},{"name":"Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-1238","authenticated-orcid":false,"given":"Kang-Il","family":"Jun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul 07804, Korea"},{"name":"Ewha Education and Research Center for Infection, Seoul 07985, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6382-4099","authenticated-orcid":false,"given":"Hae-Sun","family":"Chung","sequence":"additional","affiliation":[{"name":"Ewha Education and Research Center for Infection, Seoul 07985, Korea"},{"name":"Department of Laboratory Medicine, Ewha Womans University Seoul Hospital, Seoul 07804, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Office of Infection Control, Ewha Womans University Seoul Hospital, Seoul 07804, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihee","family":"Kim","sequence":"additional","affiliation":[{"name":"Office of Infection Control, Ewha Womans University Seoul Hospital, Seoul 07804, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jung","family":"Son","sequence":"additional","affiliation":[{"name":"Office of Infection Control, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-3814","authenticated-orcid":false,"given":"Miae","family":"Lee","sequence":"additional","affiliation":[{"name":"Ewha Education and Research Center for Infection, Seoul 07985, Korea"},{"name":"Department of Laboratory Medicine, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jung","family":"Choi","sequence":"additional","affiliation":[{"name":"Ewha Education and Research Center for Infection, Seoul 07985, Korea"},{"name":"Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(18)31727-6","article-title":"Measles outbreak in the Americas","volume":"392","author":"Fraser","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Le, N.K., Mhaskar, R., Hoare, I., Espinel, M., Fernanda Rivadeneira, M., Malavade, S., and Izurieta, R. (2017). Reemergence of Measles in the Americas: The Genotype B3 2011\u20132012 Outbreak in Ecuador. Vaccines, 5.","DOI":"10.3390\/vaccines5020015"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3346\/jkms.2017.32.11.1876","article-title":"An Outbreak of Measles in a University in Korea, 2014","volume":"32","author":"Choe","year":"2017","journal-title":"J. Korean Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hens, N., Abrams, S., Santermans, E., Theeten, H., Goeyvaerts, N., Lernout, T., Leuridan, E., Van Kerckhove, K., Goossens, H., and Van Damme, P. (2015). Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. Eurosurveillance, 20.","DOI":"10.2807\/1560-7917.ES2015.20.1.20998"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3947\/ic.2019.51.3.305","article-title":"Modified Measles in an Anti-Measles Immunoglobulin G-negative Healthcare Worker who had Received Two Doses of Measles-Containing Vaccine","volume":"51","author":"Park","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.apjtm.2016.12.003","article-title":"Measles outbreaks in the Kyeongin area of the Republic of Korea, 2013\u20132014: A single-center experience in a country of measles elimination","volume":"10","author":"Park","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3947\/ic.2019.51.1.58","article-title":"Seroprevalence of Measles in Healthcare Workers in South Korea","volume":"51","author":"Jung","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: A systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1742530","DOI":"10.1155\/2016\/1742530","article-title":"Measles Outbreak among Previously Immunized Adult Healthcare Workers, China, 2015","volume":"2016","author":"Zhang","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamapediatrics.2016.1787","article-title":"Measles and Measles Vaccination: A Review","volume":"170","author":"Bester","year":"2016","journal-title":"JAMA Pediatr."},{"key":"ref_12","unstructured":"Advisory Committee on Immunization Practices, and Centers for Disease Prevention (2011). Immunization of health-care personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep., 60, 1\u201345."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3947\/ic.2020.52.1.113","article-title":"Review of Measles in Korea: Quarantine and Elimination","volume":"52","author":"Kang","year":"2020","journal-title":"Infect. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3947\/ic.2019.51.1.54","article-title":"Preliminary Report of Seroprevalence of Anti-Measles Immunoglobulin G among Healthcare Workers of 6 Teaching Hospitals of Daegu, Korea in 2019","volume":"51","author":"Chang","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3947\/ic.2020.52.1.93","article-title":"Comparison of the Seroprevalence of Measles Antibodies among Healthcare Workers in Two Korean Hospitals in 2019","volume":"52","author":"Kwak","year":"2020","journal-title":"Infect. Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofv006","DOI":"10.1093\/ofid\/ofv006","article-title":"Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009\u20132010","volume":"2","author":"Lebo","year":"2015","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1016\/j.vaccine.2017.11.012","article-title":"Identify the susceptibility profile to measles in the general population: Serological survey of measles antibodies in Shaanxi province, China, in 2016","volume":"35","author":"Pei","year":"2017","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.vaccine.2016.04.094","article-title":"A population profile of measles susceptibility in Tianjin, China","volume":"34","author":"Boulton","year":"2016","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/j.vaccine.2017.06.058","article-title":"An increasing, potentially measles-susceptible population over time after vaccination in Korea","volume":"35","author":"Kang","year":"2017","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00406-12","article-title":"Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings","volume":"19","author":"Mercader","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2007.07.008","article-title":"Long-term persistence of antibodies after one or two doses of MMR-vaccine","volume":"25","author":"Vandermeulen","year":"2007","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coviro.2020.05.009","article-title":"Waning immunity and re-emergence of measles and mumps in the vaccine era","volume":"40","author":"Yang","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","article-title":"Waning antibody levels and avidity: Implications for MMR vaccine-induced protection","volume":"206","author":"Kontio","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1017\/S0950268819000050","article-title":"Measles and rubella seroprevalence in a population of young adult blood donors, France 2013","volume":"147","author":"Antona","year":"2019","journal-title":"Epidemiol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17488","DOI":"10.1038\/s41598-020-73618-8","article-title":"Seroprevalence of measles antibodies and factors associated with susceptibility: A national survey in Mexico using a plaque reduction neutralization test","volume":"10","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.puhe.2017.01.026","article-title":"Association between seroprevalence of measles and various social determinants in the year following a measles outbreak in Turkey","volume":"147","author":"Emek","year":"2017","journal-title":"Public Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1038\/s41598-020-62151-3","article-title":"Prevalence of Measles Antibodies in Sao Jose do Rio Preto, Sao Paulo, Brazil: A serological survey model","volume":"10","author":"Estofolete","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1016\/j.vaccine.2010.07.071","article-title":"Low measles seropositivity rate among children and young adults: A sero-epidemiological study in southern China in 2008","volume":"28","author":"Fu","year":"2010","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1017\/S0950268819002048","article-title":"Measles and rubella seroprevalence among adults in Georgia in 2015: Helping guide the elimination efforts","volume":"147","author":"Khetsuriani","year":"2019","journal-title":"Epidemiol. Infect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/21645515.2015.1032489","article-title":"Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel","volume":"11","author":"Levine","year":"2015","journal-title":"Hum. Vaccin Immunother."},{"key":"ref_32","first-page":"525","article-title":"Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: Analysis of vaccine efficacy and cost-effectiveness","volume":"32","author":"Odemis","year":"2019","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Smetana, J., Chlibek, R., Hanovcova, I., Sosovickova, R., Smetanova, L., Gal, P., and Dite, P. (2017). Decreasing Seroprevalence of Measles Antibodies after Vaccination-Possible Gap in Measles Protection in Adults in the Czech Republic. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170257"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/infdis\/jiv555","article-title":"Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults","volume":"213","author":"Fiebelkorn","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/jmv.24808","article-title":"Trend of measles, mumps, and rubella incidence following the measles-rubella catch up vaccination in the Republic of Korea, 2001","volume":"89","author":"Choe","year":"2017","journal-title":"J. Med. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4094\/CHNR.2013.19.3.216","article-title":"Subjectivity of Parents in Refusal of Childhood Vaccination: A Q-methodology Approach","volume":"19","author":"Cha","year":"2013","journal-title":"Child. Health Nurs. Res."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/5\/501\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:59:51Z","timestamp":1760162391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/5\/501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["vaccines9050501"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9050501","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]}}}